Eponyms in Oncology: Kaposi Sarcoma
This weekly series highlights eponyms in oncology. This week, we explore the history and namesake for Kaposi sarcoma.
This weekly series highlights eponyms in oncology. This week, we explore the history and namesake for Kaposi sarcoma.
Fyarro has also been added to the NCCN Guidelines as the only preferred treatment regimen for malignant PEComa.
Researchers sought to measure the risk of long-term neurocognitive outcomes in survivors of osteosarcoma and Ewing sarcoma.
The hospitalization rate was 49%, and 16% of patients died.
Respondents said some essential cancer drugs had substantial out-of-pocket costs, and some posed a high risk of catastrophic expenditure.
Young adults were more likely to receive chemotherapy.
The AACR COVID-19 and Cancer Task Force recommends keeping changes to clinical trial practices that were prompted by the pandemic.
Nab-sirolimus is an mTOR inhibitor bound to human albumin.
A statement recommends including cancer patients and survivors in COVID-19 vaccine trials.
GRASP co-founder Julia Maués explains how the initiative came about and reveals plans for the future.